Heme (iron-protoporphyrin IX) in the food vacuole of Plasmodium (None standardized; sometimes "heme" or "Fe(II)-protoporphyrin IX")

Heme (iron-protoporphyrin IX) is produced in large quantities in the food vacuole of Plasmodium parasites as a by-product of hemoglobin digestion[3][4]. Free heme is highly toxic, promoting oxidative damage and cell death if not detoxified. The parasite converts heme into inert hemozoin crystals within the vacuole to survive. This detoxification process, unique to malaria parasites, is a key therapeutic target: multiple antimalarials (notably chloroquine and artemisinins) act directly on heme or its biocrystalline conversion pathway. Heme also activates certain drugs (e.g., artemisinins) by generating reactive species that kill the parasite. Manipulating heme metabolism or its availability can modulate disease severity and drug efficacy, making intra-vacuolar heme an essential target for malaria treatment[3][4][5][1].

Other names

HematinHemozoin precursorFerriprotoporphyrin IXFe(II)/Fe(III) protoporphyrin IXIron in parasite food vacuole

Inhibition of heme detoxification (preventing conversion to hemozoin, resulting in toxic heme accumulation and parasite death – e.g., chloroquine)[3][4] Activation by heme to generate reactive metabolites (e.g., artemisinin activation via heme interaction, leading to free radical generation and parasite killing)[4] Disruption of food vacuole function or heme biosynthetic pathways[5]